Microspheres and Nanoparticles for Peptide Delivery

Delivery of peptides is a challenging task due to their poor stability toward proteolytic enzymes, their large size and poor penetration into cells. The great innovation in this field relies on the formulation of microspheres and nanoparticles to encapsulate the peptide in order to enhance its bioavailability and therapeutic efficacy.

Microparticle formulation has been successfully applied in a number of commercial products containing peptides as active pharmaceutical ingredients. The use of nanoparticles for delivering proteins and peptides are still in early stages of development and is expected to mature in near future.

To discover more on how Bachem is part of this technology in achieving successful formulation of APIs, please join our webinar on the benefits and challenges of microspheres and nanoparticles for peptide delivery.

About Bachem:
The Swiss based Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides. As a full service provider Bachem offers products for clinical development and commercial applications as well as a comprehensive catalog and exclusive custom synthesis.

Learn more about our products and services at https://www.bachem.com/

Bachem. Leading Partner in Tides